Proton Therapy for Pediatric Patients

Cancer is a formidable diagnosis, but it is even more disconcerting when it affects a child. Radiation, a traditional therapy to treat the disease, can harm a child’s growing body, resulting in developmental delays, hormone deficiencies, and restricted bone growth. Many of the pediatric patients also experience a long-term side effect from this therapy, including…

Read More

Direct-to-Consumer Genetic Testing for Inherited Cancer Risk

Morgan Turner, MS, CGC, is a Virginia-licensed and nationally board-certified, cancer-specialized genetic counselor at Inova Schar Cancer Institute. She joined Inova in June 2018. Many patients are surprised to learn that the majority of people who are diagnosed with a cancer do not have a genetic (or inherited) cause for their cancer. Indeed, it is…

Read More

Inova Awards $240K in Community Health Fund Grants to Local Nonprofits

Falls Church, VA — Inova Health System awarded $240,000 in Community Health Fund grants to 14 local nonprofit organizations this month. The Community Health Fund is an opportunity for Inova to invest in the community through partnerships that address population health needs and promote equity for all. These partnerships reinforce Inova’s ability to provide world-class…

Read More

Inova Mount Vernon Hospital Now Offering Advanced Joint Replacement Technology

Alexandria, VA – As part of Inova’s continued investment in the latest surgical technology, Inova Mount Vernon Hospital (IMVH) is proud to offer Mako SmartRobotics™ for hip and knee procedures. Mako technology allows for more precise and accurate placement of the implants around the joints, reducing complications, pain and recovery time. “Mako technology allows me…

Read More

Early Study Finds MGC018 Active in Resistant Skin Cancer

Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…

Read More

Colorectal Cancer Screening Should Begin at Age 45

Arthur Winer, MD, is a specialty care physician at Inova Schar Cancer Institute. Dr. Winer is board-certified in internal medicine, hematology and medical oncology. He is a practicing gastrointestinal medical oncologist and has clinical interests in colorectal, esophageal, gastrointestinal, liver and pancreatic cancers. For decades, experts advised people to begin colorectal cancer screening at age…

Read More

Alexandria City Council Approves Development Agreements to Transform Landmark Mall Site into Mixed-Use Community and State-of-the-Art Medical Campus

At its July 6 meeting, the Alexandria City Council unanimously approved the redevelopment agreements for the site of the former Landmark Mall, which will result in up to approximately four million square feet of new development.  The project will be anchored by the relocation and expansion of Inova’s new state-of-the-art Alexandria Hospital bringing more than…

Read More